Clinical Trial

Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in subjects with solid tumor or lymphoma.
Trial Details
NCT Number NCT07059832
Lead Sponsor First Hospital of China Medical University
Conditions Cancer
Enrollment 30 participants
Start Date 2024-04-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-11